Clinical trial Recruiting at 1 site Observational Ages 1 Year to 17

Evaluating intranasal fentanyl for pain management in pediatric emergencies

Official title: Evaluation of the "Intranasal Fentanyl" Protocol in Pediatric Surgical Emergencies at Strasbourg University Hospital

Run by University Hospital, Strasbourg, France · NCT06832046 · Data updated 2026-11-12

This study is testing if using intranasal fentanyl can effectively manage pain in children who come to the emergency room for musculoskeletal injuries.

More Musculoskeletal Pain trials

Quick facts

Study typeObservational
Ages1 Year to 17 Years
SexAll
Enrollment500 (estimated)
SponsorUniversity Hospital, Strasbourg, France
Academic / other
Locations1 site (Strasbourg)
StatusRecruiting
StartedOctober 28, 2024
Main results expectedApril 2026
Study endsApril 28, 2026
Registry record updatedFebruary 18, 2025
Trial IDNCT06832046 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children under 18 years old who received intranasal fentanyl for pain in the pediatric emergency department at Strasbourg University Hospital.

Probably not a fit

Patients who refuse participation or whose medical files are incomplete will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the use of intranasal fentanyl for managing musculoskeletal pain in children treated at the pediatric emergency department of Strasbourg University Hospital. It aims to retrospectively assess the quality of fentanyl prescriptions and the monitoring of its administration in real-world clinical practice. By analyzing patient records from August 2022 to September 2024, the study seeks to gather insights on the effectiveness and safety of this pain management protocol in emergency settings.

Why it matters

Potential benefit: If successful, this study could enhance pain management protocols for pediatric patients in emergency situations.

How similar studies have gone: Previous studies have validated the effectiveness and safety of intranasal fentanyl for pain management, suggesting a positive outlook for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Child \< 18 years old
* Child treated in the pediatric emergency department of Strasbourg University Hospital
* Child who has benefited from intranasal fentanyl between 08/01/2022 and 09/31/2024.
* Child (and/or his/her parental authority) who has not expressed, after information, his/her (their) opposition to the reuse of his/her health data for the purposes of this research.

Exclusion Criteria:

* Refusal of the child (and/or his/her parent) to participate in the study
* Patient's medical file not incomplete
* Child not domiciled in France.

Where it's running

  • Service d'Urgences Médico-Chirurgicales Pédiatriques - CHU de Strasbourg - France
    Strasbourg, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.